-
CTE can rob a person of their memories and ability to make decisions and plans. It can also cause a person to become a threat to themselves and, sometimes, others. But the disease, caused by repeated head trauma, can't be definitively diagnosed before death. A San Antonio researcher hopes to help change that.
-
Exercise can improve function and slow disease progression in people with Parkinson's disease, but why? A UT Health San Antonio researcher is studying patients who exercise and play virtual reality games to see if she can figure out the answer.
-
Pediatrician Debra Hendrickson says climate change is the greatest crime ever committed against children. She's written a book detailing the impact of climate change on children's health and offers a call-to-action for parents and other adults to do something before it really is too late.
-
Millions of Americans are suffering from undiagnosed illnesses. Many are told their symptoms are imagined. Could artificial intelligence change the game, figuring out how to diagnose rare and difficult to diagnose diseases, leading to better understanding of their causes and better treatments? One San Antonio researcher thinks so.
-
The CDC has released its Adult Obesity Prevalence Maps for 2023, and more than 35 percent of the adults in 23 states are obese. Texas just misses that mark, with 34.4 percent of adult Texans experiencing obesity.
-
Dr. Jason Bowling said that if you've had COVID in the last two to three months, you can wait to get a new vaccine, as most people will have some protection with natural immunity for that limited length of time. If you have not been infected with COVID yet in this go-around, Bowling urges you to get your vaccine as soon as possible.
-
CVS and Walgreens have begun to take appointments for the new COVID booster during a KP variant-fueled surge. The booster targets omicron subvariant KP.2. Uninsured adults will no longer get free COVID vaccines under the CDC's Bridge Access Program, which ends this month.
-
The FDA recently approved the anti-amyloid drug donanemab, sold as Kisunla. The medication can delay cognitive decline in early Alzheimer's patients by about seven months, but it is expensive and can have serious side effects. Still, it will be soon be available for some patients in South Texas.
-
A virologist and vaccine researcher at Texas Biomedical Research Institute explains the difference between H5N1 and H5N2 and what the fatal human case of H5N2 in Mexico City might mean for humans.
-
'It'll be rough through January, most of February, likely. And then hopefully we'll start to see some relief,' according to Dr. Jason Bowling, an infectious diseases doctor at UT Health San Antonio and University Hospital.